Bliss GVS Pharma Limited (BLISSGVS.NS) NSE
434.45
+32(+7.95%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 24.22B |
| Enterprise Value | 24.09B |
| P/E Ratio | 36.6 |
| PEG Ratio | 0.71 |
| Price/Sales Ratio | 4.96 |
| Price/Book Ratio | 3.96 |
| Enterprise/Revenue | 4.94 |
| Enterprise/EBITDA | 19.49 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.14 |
| Operating Margin | 0.13 |
Management Effectiveness
| Return On Assets | 0.09 |
| Return On Equity | 0.12 |
Income Statement
| Revenue | 9.27B |
| Revenue/Share | 85.22 |
| Gross Profit | 5.02B |
| EBITDA | 2.35B |
| Net Income | 1.29B |
| Diluted EPS | 12 |
Balance Sheet
| Total Cash | 2.27B |
| Total Cash/Share | 20.86 |
| Total Debt | 217.5M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 4.02 |
| Book Value Per Share | 113.22 |
Price History
| 52-Week Change | 224.85 |
| 52-Week High | 442.65 |
| 52-Week Low | 118 |
| Moving Average 50 Days | 278.83 |
| Moving Average 200 Days | 198.07 |
Statistics
| Average Volume | 2.53M |
| Shares Outstanding | 105.79M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1 |
| Trailing Annual Dividend Yield | 0.23 |
| Payout Ratio | 0.04 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
